Conversare OÜ

Active Registry code 14285549 OÜ Tallinn Registered 29 Jun 2017
Compare

Conversare OÜ is a OÜ based in Tallinn, registry code 14285549, status: active. Main activity: Medical specialists activities. Its annual report for 2024 shows revenue of €18 770 and 0 employees.

Turnover
—
State taxes
500 €
Labour taxes
0 €
Employees
—

Q3 2024 · data from the Tax and Customs Board (EMTA)

Position in the industry Human health activities · EMTAK 86

  • Revenue · 2024 18 770 €
    industry median 20 000 € · companies in the industry: 3 347
  • Net profit margin · 2024 14.3 %
    industry median 10.7 % · companies in the industry: 2 757

Taxes and turnover

Q3 2024 – Q3 2024
State taxes, € Q3 2024: 500 €
0100200300400500Q3 2024 Company: 500 €Q3·240100200300400500Q3 2024 Company: 500 €Q3·24
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2024 — 500 — —

Financials by year

2017 – 2024
Revenue, € 2024: 18 770 € · +49.1% vs 2023 · industry median 20 000 € · above 49% of the industry
010 00020 00030 0002017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 4 727 € Industry median: 25 166 €20192020 Company: 7 987 € Industry median: 20 220 €20202021 Company: 4 049 € Industry median: 20 121 €20212022 Company: 6 660 € Industry median: 20 030 €20222023 Company: 12 590 € Industry median: 19 469 €20232024 Company: 18 770 € Industry median: 20 000 €2024010 00020 00030 0002017 Company: — Industry median: —2018 Company: — Industry median: —20182019 Company: 4 727 € Industry median: 25 166 €2020 Company: 7 987 € Industry median: 20 220 €20202021 Company: 4 049 € Industry median: 20 121 €2022 Company: 6 660 € Industry median: 20 030 €20222023 Company: 12 590 € Industry median: 19 469 €2024 Company: 18 770 € Industry median: 20 000 €2024
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2024: 2 690 € · −50.1% vs 2023 · industry median 1 621 € · above 54% of the industry
-7 500-5 000-2 50002 5005 0007 5002017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: -6 688 € Industry median: 2 596 €20192020 Company: 2 824 € Industry median: 2 208 €20202021 Company: -5 820 € Industry median: 1 834 €20212022 Company: -465 € Industry median: 1 525 €20222023 Company: 5 394 € Industry median: 1 745 €20232024 Company: 2 690 € Industry median: 1 621 €2024-7 500-5 000-2 50002 5005 0007 5002017 Company: — Industry median: —2018 Company: — Industry median: —20182019 Company: -6 688 € Industry median: 2 596 €2020 Company: 2 824 € Industry median: 2 208 €20202021 Company: -5 820 € Industry median: 1 834 €2022 Company: -465 € Industry median: 1 525 €20222023 Company: 5 394 € Industry median: 1 745 €2024 Company: 2 690 € Industry median: 1 621 €2024
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2024: 14.3 % · −28.5 pp vs the year before · industry median 10.7 % · above 56% of the industry
-150-100-500502017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: -141.5 % Industry median: 10.3 %20192020 Company: 35.4 % Industry median: 12.4 %20202021 Company: -143.7 % Industry median: 13.0 %20212022 Company: -7.0 % Industry median: 11.3 %20222023 Company: 42.8 % Industry median: 11.4 %20232024 Company: 14.3 % Industry median: 10.7 %2024-150-100-500502017 Company: — Industry median: —2018 Company: — Industry median: —20182019 Company: -141.5 % Industry median: 10.3 %2020 Company: 35.4 % Industry median: 12.4 %20202021 Company: -143.7 % Industry median: 13.0 %2022 Company: -7.0 % Industry median: 11.3 %20222023 Company: 42.8 % Industry median: 11.4 %2024 Company: 14.3 % Industry median: 10.7 %2024
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2024: 22 696 € · +16.4% vs 2023
05 00010 00015 00020 00025 0002017 Company: —20172018 Company: —20182019 Company: 17 573 €20192020 Company: 20 397 €20202021 Company: 14 577 €20212022 Company: 14 112 €20222023 Company: 19 506 €20232024 Company: 22 696 €202405 00010 00015 00020 00025 0002017 Company: —2018 Company: —20182019 Company: 17 573 €2020 Company: 20 397 €20202021 Company: 14 577 €2022 Company: 14 112 €20222023 Company: 19 506 €2024 Company: 22 696 €2024
Equity, € 2024: 22 696 € · +16.4% vs 2023
05 00010 00015 00020 00025 0002017 Company: —20172018 Company: —20182019 Company: 17 573 €20192020 Company: 20 397 €20202021 Company: 14 577 €20212022 Company: 14 112 €20222023 Company: 19 506 €20232024 Company: 22 696 €202405 00010 00015 00020 00025 0002017 Company: —2018 Company: —20182019 Company: 17 573 €2020 Company: 20 397 €20202021 Company: 14 577 €2022 Company: 14 112 €20222023 Company: 19 506 €2024 Company: 22 696 €2024
Employees 2024: 0 · industry median 2 · above 2% of the industry
01232017 Company: 0 Industry median: —20172018 Company: 0 Industry median: 320182019 Company: 0 Industry median: 320192020 Company: 0 Industry median: 320202021 Company: 0 Industry median: 2.520212022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 220232024 Company: 0 Industry median: 2202401232017 Company: 0 Industry median: —2018 Company: 0 Industry median: 320182019 Company: 0 Industry median: 32020 Company: 0 Industry median: 320202021 Company: 0 Industry median: 2.52022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 22024 Company: 0 Industry median: 22024
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2024 18 770 2 690 0 22 696 22 696 0
2023 12 590 5 394 0 19 506 19 506 0
2022 6 660 -465 0 14 112 14 112 0
2021 4 049 -5 820 0 14 577 14 577 0
2020 7 987 2 824 0 20 397 20 397 0
2019 4 727 -6 688 0 17 573 17 573 0
2018 — — — — — 0
2017 — — — — — 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2024

Net profit margin
14.3 %
Net profit / revenue
Return on equity (ROE)
11.9 %
Net profit / equity
Return on assets (ROA)
11.9 %
Net profit / assets
Equity ratio
100.0 %
Equity / assets

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2024 1 Jan 2024 – 31 Dec 2024 10 Nov 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 8 Aug 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 14 Jul 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 14 Jun 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 29 Sep 2021 Company’s own e-Äriregister
2019 1 Jan 2019 – 31 Dec 2019 28 Oct 2020 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 86221Medical specialists activities Main
Rulings
Number, date Title Deadline State Document
Ä 50058812 / M2
12 Jul 2024
Warning of deletion from the register: annual report not filed 15 Oct 2024 Deficiencies eliminated
9 Aug 2024
PDF
Ä 50058812 / 7
5 Apr 2024
Amendment entry In force
5 Apr 2024
PDF
Ä 50058812 / 6
2 Sep 2023
Amendment entry In force
2 Sep 2023
PDF
Ä 50058812 / 5
30 Sep 2021
Amendment entry In force
30 Sep 2021
PDF
Ä 50058812 / 4
20 Jan 2018
Amendment entry In force
20 Jan 2018
PDF
Ä 50058812 / 3
19 Dec 2017
Amendment entry In force
19 Dec 2017
PDF
Ä 50058812 / 2
13 Dec 2017
Amendment entry In force
13 Dec 2017
PDF
Ä 50058812
29 Jun 2017
First entry In force
29 Jun 2017
PDF
Ä 50058812 / M1
6 Jun 2017
Ruling to eliminate deficiencies 6 Jul 2017 Deficiencies eliminated
29 Jun 2017
PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data